On Invalid Date, Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 2023 earnings per share (EPS) of -$1.45, up 9.02% year over year. Total Phathom Pharmaceuticals earnings for the quarter were -$79.57 million. In the same quarter last year, Phathom Pharmaceuticals's earnings per share (EPS) was -$1.33.
As of Q1 2024, Phathom Pharmaceuticals's earnings has grown year over year. Phathom Pharmaceuticals's earnings in the past year totalled -$201.59 million.
What is PHAT's earnings date?
Phathom Pharmaceuticals's earnings date is Invalid Date. Add PHAT to your watchlist to be reminded of PHAT's next earnings announcement.
What was PHAT's revenue last quarter?
On Invalid Date, Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 2023 revenue of $682.00 thousand up Infinity% year over year. In the same quarter last year, Phathom Pharmaceuticals's revenue was $0.00.
What was PHAT's revenue growth in the past year?
As of Q1 2024, Phathom Pharmaceuticals's revenue has grown null year over year. Phathom Pharmaceuticals's revenue in the past year totalled $682.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.